Roche Diagnostics' Sales Rise 4 Percent as Applied Science Unit Continues to Struggle | GenomeWeb

NEW YORK (GenomeWeb News) – Roche today reported that sales for its diagnostics division grew 4 percent year over year at constant exchange rates for the first nine months of 2012, with molecular diagnostics showing single-digit growth and the applied science unit continuing to struggle.

For the nine months ended Sept. 30, Roche reported total diagnostics sales of CHF 7.50 billion ($8.09 billion) compared to CHF 7.10 billion for the first nine months of 2011. In Swiss francs its diagnostics sales were up 6 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.